Yup.

If the vote passes OK, these files will land in central as well.

T

On Mon, Dec 18, 2023 at 9:59 PM <mark.yagnatin...@barclays.com.invalid>
wrote:

> Ah, much better!  I guess I can ignore the cyclondex files and grab a
> plain old zip?
>
> -----Original Message-----
> From: Tamás Cservenák <ta...@cservenak.net>
> Sent: Monday, December 18, 2023 3:49 PM
> To: Maven Users List <users@maven.apache.org>
> Cc: subharaj.ma...@gmail.com
> Subject: Re: Maven 4.0 release timeline
>
>
> CAUTION: This email originated from outside our organisation -
> ta...@cservenak.net Do not click on links, open attachments, or respond
> unless you recognize the sender and can validate the content is safe.
> I really recommend alpha10, distros are here
> https://clicktime.symantec.com/15t6V3WB3Q9UkWhf5JPD6?h=DNfkwbsM2Nbwr9Re8FSzo--npL69CABPYMYoaHsSC-A=&u=https://repository.apache.org/content/repositories/maven-2050/org/apache/maven/apache-maven/4.0.0-alpha-10/
>
> Thanks
> T
>
> On Mon, Dec 18, 2023, 21:48 <mark.yagnatin...@barclays.com.invalid> wrote:
>
> > Navigating that directory tree seems a bit intimidating... can I try
> > alpha-8 or better wait for alpha-10 to officially come out?
> >
> > -----Original Message-----
> > From: Tamás Cservenák <ta...@cservenak.net>
> > Sent: Monday, December 18, 2023 3:43 PM
> > To: Maven Users List <users@maven.apache.org>
> > Cc: subharaj.ma...@gmail.com
> > Subject: Re: Maven 4.0 release timeline
> >
> >
> > CAUTION: This email originated from outside our organisation -
> > ta...@cservenak.net Do not click on links, open attachments, or
> > respond unless you recognize the sender and can validate the content is
> safe.
> > ...or,.just go to staging repo
> >
> > https://clicktime.symantec.com/15siaWLYGbnA1MrGqWQwt?h=qkVv-eG-rGmVca6
> > UeWqg9iHAifq1sVHsvsDmSfLKZ2o=&u=https://clicktime.symantec.com/15t6QDJ
> > tanTtLZsjXjz4U?h=4Jzcps2egc7Hk1dplHDiulcv9nRA0wSTiAQlv1W8Bro=&u=https:
> > //repository.apache.org/content/repositories/maven-2050
> > download the distro and try on some of your projects?
> >
> > In case of problems be so kind to report the issues so we can iron
> > them out.
> >
> > Imho, alpha 10 is in very good shape. Alpha-9 had a nasty bug and
> > could remain running the process. Do not use it.
> >
> > Thanks
> > T
> >
> > On Mon, Dec 18, 2023, 21:39 <mark.yagnatin...@barclays.com.invalid>
> wrote:
> >
> > > I'm not the original asker but this kind of answer tends to annoy me.
> > > Yes, there is no "official" release timeline, you're obviously not
> > > going to promise anything, all this is (hopefully?) clear, BUT!
> > > You no doubt have GUESSES.  And your guesses are no doubt better
> > > than that of most uninformed outsiders.
> > > As an outsider, I have no idea what the "status" of maven 4 is, and
> > > I can't even begin to guess how I would find out.
> > > Should I try to catch up on the last few years of traffic on the
> > > developer email lists?
> > > Or perhaps the answer can be divined from the issue tracker?  If so,
> how?
> > > Is it expected that alpha-10 will be the last alpha, and the next
> > > build will be a beta?
> > > If that is NOT what you expect, then what's the primary hold up?
> > > Are there major features that have yet to be implemented?
> > > Or perhaps the features are mostly done but they're still a bit buggy?
> > > Or perhaps the code quality is pretty solid and you just want to
> > > reserve the right to make backwards incompatible changes, and
> > > there's a policy to not do that after hitting beta?
> > >
> > > You get the idea.  As an insider, you probably think to yourself
> > > "there's no telling when we'll be done; it depends on a zillion
> > > unpredictable things".
> > > But as outsiders, we don't even know whether the ETA is a few months
> > > or a few years or a few decades or perhaps just a few weeks.
> > >
> > > Sorry if that came off as a bit of a rant :)
> > >
> > >
> > > -----Original Message-----
> > > From: Karl Heinz Marbaise <khmarba...@gmx.de.INVALID>
> > > Sent: Monday, December 18, 2023 3:18 PM
> > > To: Maven Users List <users@maven.apache.org>; Debraj Manna <
> > > subharaj.ma...@gmail.com>
> > > Subject: Re: Maven 4.0 release timeline
> > >
> > >
> > > CAUTION: This email originated from outside our organisation -
> > > khmarba...@gmx.de.INVALID Do not click on links, open attachments,
> > > or respond unless you recognize the sender and can validate the
> > > content is safe.
> > > On 18.12.23 06:27, Debraj Manna wrote:
> > > > Can someone let me know when Maven 4 is expected to be released?
> > > > Where can I view its release timelines?
> > > >
> > >
> > > We are an open source project. We don't have a release timeline.
> > >
> > > Maven 4.0.0 will be there when it's there.
> > >
> > >
> > > If you want to help testing, there is 4.0.0-alpha-9 version
> > > available (at the moment the VOTE for 4.0.0-alpha-10 is running
> developers list)..
> > >
> > >
> > >
> > > https://clicktime.symantec.com/15t6EYvKfZ6hWgDtSdBmE?h=enuexfuM5c9xR
> > > Z5X0oZzhj669n395kTA5hIdhUOxXyY=&u=https://clicktime.symantec.com/15t
> > > 5ejZL3AGSyEFA9Aedx?h%3DABJzOQGm-e1Zxyu
> > > IqUZPLWnHHC2LmzcP6V9UINAuTSc=&u=https://clicktime.symantec.com/15t5j
> > > Zkcus1931GMBGnsW?h=aAZLedKsowXWW-3Z-WnWmkI4H71A9BrQiqYTxH6hqWk=&u=ht
> > > tps://clicktime.symantec.com/15siQqw
> > > yMNQyBUCRkPcee?h=-wnFgkT4h16bjz0t2Vuc_NutxQbPp0L_p6KY3P3WB2E=&u=https:
> > > //maven.apache.org/download.cgi
> > >
> > > https://clicktime.symantec.com/15t69ij3CwR76jPxu4ncc?h=GfK7jRGQ-5KWG
> > > I6Z9jbAEouZQPMl7EIW6YcQIomuX0o=&u=https://clicktime.symantec.com/15t
> > > 5ZuN3aYarZHREbcFVL?h%3Df4YJm-aS7T_bpjO
> > > AtqB_jneksRphxbi0aG911AdXT1E=&u=https://clicktime.symantec.com/15t5e
> > > jZLTFKYd4SRdiPit?h=LX1jJOzqd3bLwq21pgLA2NMdovCdqX9n1GXAPx3KO70=&u=ht
> > > tps://clicktime.symantec.com/15siL1k
> > > gtkjNmXNWCqDW2?h=BX1saw3vPZ85tRY4Qc9ZmbpOGkojF6vC2umq1TvP1eM=&u=https:
> > > //maven.apache.org/docs/history.html
> > >
> > > https://clicktime.symantec.com/15t6KP7c8AnHvd3ozBaur?h=-70HebZ3AGRsC
> > > g_xOyWXFdOomJjDXv_uRyYtHU93KN4=&u=https://clicktime.symantec.com/15t
> > > 5jZkcVmx3PB55gj3na?h%3DL9e7tA5cT0v2zyk
> > > QUoinwwWFS6c1VuE5zuM7Lmb8XwE=&u=https://clicktime.symantec.com/15t5p
> > > PwuNUgjSx6GiqC28?h=WWvg4OngLTq1LcWEVErBEolB35AOOYBjFU0blXj6fFw=&u=ht
> > > tps://clicktime.symantec.com/15siVg9
> > > Foz6ZbR2MHx1oG?h=C_JJFO_gli3dfK9BJoJ1t22_wu2YHA7V4ywpVxFiPlA=&u=https:
> > > //maven.apache.org/mailing-lists.html
> > >
> > > Kind regards
> > > Karl Heinz Marbaise
> > > Apache Maven PMC Chairman
> > >
> > >
> > > --------------------------------------------------------------------
> > > - To unsubscribe, e-mail: users-unsubscr...@maven.apache.org
> > > For additional commands, e-mail: users-h...@maven.apache.org
> > >
> > > This message is for information purposes only. It is not a
> > > recommendation, advice, offer or solicitation to buy or sell a
> > > product or service, nor an official confirmation of any transaction.
> > > It is directed at persons who are professionals and is intended for
> > > the
> > > recipient(s) only. It is not directed at retail customers. This
> > > message
> > is subject to the terms at:
> > >
> > https://clicktime.symantec.com/15sizfJxZgC855ytZJQgz?h=3voR8g2XaCqfAjj
> > ZLcBvchvlPd7niApVYl9kKJuW4X0=&u=https://clicktime.symantec.com/15t79h4
> > SiKcE45K3RmaQ4?h=386zNjhGjtFZKMcyKar2TV3Jafl02hA62LukYLYLoOw=&u=https:
> > //www.cib.barclays/disclosures/web-and-email-disclaimer.html
> > .
> > >
> > > For important disclosures, please see:
> > > https://clicktime.symantec.com/15t64tXkkKjWgna3MWPTz?h=h0k-k9gHX0Jyo
> > > DG3-dmiqOdkwCPKPoLqP_QnwQr4QZQ=&u=https://clicktime.symantec.com/15s
> > > iuq7g74WXf99y1k1YN?h%3DIswND1SsUj6jPBn
> > > AQ25pI03Yrip4Fb40LbWhFeGfT3A=&u=https://clicktime.symantec.com/15t6z
> > > 2fso6F3EBfCLen6p?h=oGETYLl2q3nwGdR6oFnB55WYr5GiCe8J19ndBR4sQc4=&u=ht
> > > tps://www.cib.barclays/disclosures/s
> > > ales-and-trading-disclaimer.html regarding marketing commentary from
> > > Barclays Sales and/or Trading desks, who are active market
> > > participants;
> > > https://clicktime.symantec.com/15t5uE9Bq6NKrtvCGPbAk?h=WGT2rvU9dccDE
> > > BzxBdoj1uiE_iBgRhroqOA77z94TS8=&u=https://clicktime.symantec.com/15s
> > > ifLXpjDTkRJgCP4p6W?h%3DvgA6hjZek3ZVk_x
> > > Kn8kqhC6hIQRHHWp-8qQNmirXDGY=&u=https://clicktime.symantec.com/15t6Z
> > > shTW1q5ATXacrnMi?h=spOS7WUPKlYI9BbNCie3WBvSe0GcdKyXzRR5qsqneVM=&u=ht
> > > tps://www.cib.barclays/disclosures/b
> > > arclays-global-markets-disclosures.html
> > > regarding our standard terms for Barclays Corporate and Investment
> > > Bank where we trade with you in principal-to-principal wholesale
> > > markets transactions; and in respect to Barclays Research, including
> > > disclosures relating to specific issuers, see:
> > https://clicktime.symantec.com/15siFBZQS93nMaYafGpMQ?h=7SEAYHsYc8GqllC
> > A9QU7CPBG1yVxx6q0UKBl4DhkexA=&u=https://clicktime.symantec.com/15t5ZuN
> > 3zddxD7cW69zaG?h=Gl-gefN79RuR94I07-xb-Tk-CNam0oH1c_-Kw0CHjME=&u=http:/
> > /publicresearch.barclays.com
> > .
> > > ____________________________________________________________________
> > > __
> > > ____________
> > >
> > > If you are incorporated or operating in Australia, read these
> > > important
> > > disclosures:
> > > https://clicktime.symantec.com/15t5z4LUHi3vGqk7owzKN?h=bwfDHtKrv5i1Z
> > > gB7KkBCNcXgzRVO57du15ATmihmdOY=&u=https://clicktime.symantec.com/15s
> > > ikAj7Bq9LqFW7vdDF8?h%3DF4wY-fRb3iEFXGV
> > > Uf81j9jMY86UU5tAvr_lkw6Z9n6c=&u=https://clicktime.symantec.com/15t6j
> > > Y62RFCFzMBRhyaex?h=8H2v29dFh8_nyx8ylhln9299w5TnsB-S1cra0oWHuqk=&u=ht
> > > tps://www.cib.barclays/disclosures/i
> > > mportant-disclosures-asia-pacific.html
> > > .
> > >
> > > ____________________________________________________________________
> > > __ ____________ For more details about how we use personal
> > > information, see our privacy
> > > notice:
> > https://clicktime.symantec.com/15sipzvPeSpwFCL3UBcPk?h=Rip9XxtA8tlObzI
> > skgzvnMyDxXh7aMSApsjmEUDZC6E=&u=https://clicktime.symantec.com/15t6uCU
> > bLUZSpEqGo6NxC?h=mLknyfmRXQOw-fmrFE4MBWUqoH4MUrsr9JBCKcjXSFw=&u=https:
> > //www.cib.barclays/disclosures/personal-information-use.html
> > .
> > >
> > >
> > > ____________________________________________________________________
> > > __
> > > ____________
> > >
> >
> > This message is for information purposes only. It is not a
> > recommendation, advice, offer or solicitation to buy or sell a product
> > or service, nor an official confirmation of any transaction. It is
> > directed at persons who are professionals and is intended for the
> > recipient(s) only. It is not directed at retail customers. This message
> is subject to the terms at:
> >
> https://clicktime.symantec.com/15t79h4SiKcE45K3RmaQ4?h=386zNjhGjtFZKMcyKar2TV3Jafl02hA62LukYLYLoOw=&u=https://www.cib.barclays/disclosures/web-and-email-disclaimer.html
> .
> >
> > For important disclosures, please see:
> > https://clicktime.symantec.com/15t74rsAFhvde8V7tDBFS?h=QjPu8g1jFYzvYdV
> > J2BDV142aPSXozhBk9q-B7uRMp8g=&u=https://www.cib.barclays/disclosures/s
> > ales-and-trading-disclaimer.html regarding marketing commentary from
> > Barclays Sales and/or Trading desks, who are active market
> > participants;
> > https://clicktime.symantec.com/15t6ehtjxdWfaQMWARBWL?h=rSTsOsqRWtP81fx
> > lenIXFl2JNFS0vFu3YcaVOp4RJJI=&u=https://www.cib.barclays/disclosures/b
> > arclays-global-markets-disclosures.html
> > regarding our standard terms for Barclays Corporate and Investment
> > Bank where we trade with you in principal-to-principal wholesale
> > markets transactions; and in respect to Barclays Research, including
> > disclosures relating to specific issuers, see:
> https://clicktime.symantec.com/15t5ZuN3zddxD7cW69zaG?h=Gl-gefN79RuR94I07-xb-Tk-CNam0oH1c_-Kw0CHjME=&u=http://publicresearch.barclays.com
> .
> > ______________________________________________________________________
> > ____________
> >
> > If you are incorporated or operating in Australia, read these
> > important
> > disclosures:
> > https://clicktime.symantec.com/15t6pNHJsrsrQJ1MFXyoa?h=Q2M2Ym9iHv7RNTK
> > YvwJ0mMzeplKI2KAcu1W5GwEphIw=&u=https://www.cib.barclays/disclosures/i
> > mportant-disclosures-asia-pacific.html
> > .
> >
> > ______________________________________________________________________
> > ____________ For more details about how we use personal information,
> > see our privacy
> > notice:
> https://clicktime.symantec.com/15t6uCUbLUZSpEqGo6NxC?h=mLknyfmRXQOw-fmrFE4MBWUqoH4MUrsr9JBCKcjXSFw=&u=https://www.cib.barclays/disclosures/personal-information-use.html
> .
> >
> >
> > ______________________________________________________________________
> > ____________
> >
> > ---------------------------------------------------------------------
> > To unsubscribe, e-mail: users-unsubscr...@maven.apache.org
> > For additional commands, e-mail: users-h...@maven.apache.org
>
> This message is for information purposes only. It is not a recommendation,
> advice, offer or solicitation to buy or sell a product or service, nor an
> official confirmation of any transaction. It is directed at persons who are
> professionals and is intended for the recipient(s) only. It is not directed
> at retail customers. This message is subject to the terms at:
> https://www.cib.barclays/disclosures/web-and-email-disclaimer.html.
>
> For important disclosures, please see:
> https://www.cib.barclays/disclosures/sales-and-trading-disclaimer.html
> regarding marketing commentary from Barclays Sales and/or Trading desks,
> who are active market participants;
> https://www.cib.barclays/disclosures/barclays-global-markets-disclosures.html
> regarding our standard terms for Barclays Corporate and Investment Bank
> where we trade with you in principal-to-principal wholesale markets
> transactions; and in respect to Barclays Research, including disclosures
> relating to specific issuers, see: http://publicresearch.barclays.com.
> __________________________________________________________________________________
>
> If you are incorporated or operating in Australia, read these important
> disclosures:
> https://www.cib.barclays/disclosures/important-disclosures-asia-pacific.html
> .
>
> __________________________________________________________________________________
> For more details about how we use personal information, see our privacy
> notice: https://www.cib.barclays/disclosures/personal-information-use.html.
>
>
> __________________________________________________________________________________
>

Reply via email to